Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection

Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection

US Patent 5820869 · Granted Oct 13, 1998

Estimated economic value: $141,849,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Attenuated bovine coronavirus and related vaccines2019
Allergy inhibitor compositions and kits and methods of using the same2018
Mycoplasma hyopneumoniae bacterin vaccine2016
Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine2015
Vaccines with live bacterial isolates for systemic administration2014
Allergy inhibitor compositions and kits and methods of using the same2014
Raccoon poxvirus expressing rabies glycoproteins2014
Vaccine against Ehrlichia canis2014
Methods of immunizing pregnant heifers at three months of gestation2013
Canine Lyme disease vaccine2013
Allergy inhibitor compositions and kits and methods of using the same2013
Mycoplasma hyopneumoniae bacterin vaccine2012